183 related articles for article (PubMed ID: 34372612)
1. Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma.
Islam S; Espitia CM; Persky DO; Carew JS; Nawrocki ST
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372612
[TBL] [Abstract][Full Text] [Related]
2. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
Zhang Q; Lee B; Korecka M; Li G; Weyland C; Eck S; Gessain A; Arima N; Lessin SR; Shaw LM; Luger S; Kamoun M; Wasik MA
Leuk Res; 1999 Apr; 23(4):373-84. PubMed ID: 10229324
[TBL] [Abstract][Full Text] [Related]
3. Superoxide-Generating Nox5α Is Functionally Required for the Human T-Cell Leukemia Virus Type 1-Induced Cell Transformation Phenotype.
Shigemura T; Shiohara M; Kato M; Furuta S; Kaneda K; Morishita K; Hasegawa H; Fujii M; Gorlach A; Koike K; Kamata T
J Virol; 2015 Sep; 89(17):9080-9. PubMed ID: 26109726
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Matsuda T; Tanaka Y; Ohshiro K; Mori N
Retrovirology; 2006 Apr; 3():22. PubMed ID: 16603085
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.
Maude SL; Dolai S; Delgado-Martin C; Vincent T; Robbins A; Selvanathan A; Ryan T; Hall J; Wood AC; Tasian SK; Hunger SP; Loh ML; Mullighan CG; Wood BL; Hermiston ML; Grupp SA; Lock RB; Teachey DT
Blood; 2015 Mar; 125(11):1759-67. PubMed ID: 25645356
[TBL] [Abstract][Full Text] [Related]
6. Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia.
Zhang M; Mathews Griner LA; Ju W; Duveau DY; Guha R; Petrus MN; Wen B; Maeda M; Shinn P; Ferrer M; Conlon KD; Bamford RN; O'Shea JJ; Thomas CJ; Waldmann TA
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12480-5. PubMed ID: 26396258
[TBL] [Abstract][Full Text] [Related]
7. Anti-adult T‑cell leukemia/lymphoma activity of cerdulatinib, a dual SYK/JAK kinase inhibitor.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2018 Oct; 53(4):1681-1690. PubMed ID: 30066853
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.
Cheng J; Zhang D; Zhou C; Marasco WA
Leuk Res; 2004 Jan; 28(1):71-82. PubMed ID: 14630083
[TBL] [Abstract][Full Text] [Related]
9. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins.
Takemoto S; Mulloy JC; Cereseto A; Migone TS; Patel BK; Matsuoka M; Yamaguchi K; Takatsuki K; Kamihira S; White JD; Leonard WJ; Waldmann T; Franchini G
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13897-902. PubMed ID: 9391124
[TBL] [Abstract][Full Text] [Related]
10. Human and simian T-cell leukemia viruses type 2 (HTLV-2 and STLV-2(pan-p)) transform T cells independently of Jak/STAT activation.
Mulloy JC; Migone TS; Ross TM; Ton N; Green PL; Leonard WJ; Franchini G
J Virol; 1998 May; 72(5):4408-12. PubMed ID: 9557732
[TBL] [Abstract][Full Text] [Related]
11. Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer.
Carew JS; Espitia CM; Zhao W; Kelly KR; Coffey M; Freeman JW; Nawrocki ST
Cell Death Dis; 2013 Jul; 4(7):e728. PubMed ID: 23868061
[TBL] [Abstract][Full Text] [Related]
12. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
[TBL] [Abstract][Full Text] [Related]
13. Inducible nitric oxide synthase mediates DNA double strand breaks in Human T-Cell Leukemia Virus Type 1-induced leukemia/lymphoma.
Baydoun HH; Cherian MA; Green P; Ratner L
Retrovirology; 2015 Aug; 12():71. PubMed ID: 26265053
[TBL] [Abstract][Full Text] [Related]
14. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I.
Migone TS; Lin JX; Cereseto A; Mulloy JC; O'Shea JJ; Franchini G; Leonard WJ
Science; 1995 Jul; 269(5220):79-81. PubMed ID: 7604283
[TBL] [Abstract][Full Text] [Related]
15. Novel role for interleukin-2 receptor-Jak signaling in retrovirus transmission.
Taylor JM; Brown M; Nejmeddine M; Kim KJ; Ratner L; Lairmore M; Nicot C
J Virol; 2009 Nov; 83(22):11467-76. PubMed ID: 19726513
[TBL] [Abstract][Full Text] [Related]
16. Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1.
Cataldi M; Shah NR; Felt SA; Grdzelishvili VZ
Virology; 2015 Nov; 485():340-54. PubMed ID: 26331681
[TBL] [Abstract][Full Text] [Related]
17. Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia.
Betancourt D; Ramos JC; Barber GN
J Virol; 2015 Dec; 89(23):11786-800. PubMed ID: 26378177
[TBL] [Abstract][Full Text] [Related]
18. JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models.
Patel MR; Dash A; Jacobson BA; Ji Y; Baumann D; Ismail K; Kratzke RA
Cancer Gene Ther; 2019 Nov; 26(11-12):411-418. PubMed ID: 30622322
[TBL] [Abstract][Full Text] [Related]
19. Bio-distribution study of Reolysin® (pelareorep) through a single intravenous infusion in Sprague-Dawley rats.
Chakrabarty R; Tran H; Boulay I; Moran T; Parenteau A; Tavcar R; Bigras M; Hagerman A; Serl S; Thompson B; Coffey M
Invest New Drugs; 2013 Dec; 31(6):1476-86. PubMed ID: 24121993
[TBL] [Abstract][Full Text] [Related]
20. Noncanonical Cell Death Induction by Reassortant Reovirus.
Rodríguez Stewart RM; Raghuram V; Berry JTL; Joshi GN; Mainou BA
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
